Phosphorylated and Branched DPD Analogs as Quorum Sensing Inhibitors in Bacteria
University of Maryland
posted on 08/18/2010
Inventors at the University of Maryland, College Park have created unique QS inhibiting AI-2 (Autoinducer-1) based analogs that disrupt biofilm formation and consequently bacterial pathogenicity. Researchers have shown for the first time that phosphorylated branched DPD (dihydroxy-pentane-dione) AI-2 analogs are QS antagonists. They can replace the previously used AHL inhibitors which are species specific. The ubiquitous AI-2 is capable of inhibiting and modulating QS among multiple pathogenic species simultaneously. These quorum quenching analogs could potentially have extensive applications in both medical and non-medical fields.
Suggested Uses
- Easy to use tool-kit with specific analogs ideal for commercialization.
- Ideal for treating gut infections where analogs could differentiate between the pathogens from mutualistic organisms using differentially constructed AI-2 analogs.
- Utility in Surgical implants and catheters prone to biofilm induced infections.
- Potential assistance in Bio-fermentation.
- Marine Biofilm formation prevention.
Advantages
- Based on the C1-alkyl chain length in the AI-2 analogs, this system could potentially modulate QS en mass or selectively.
- The ability to selectively target pathogenic bacteria from the non-pathogenic ones has important clinical implications.
- The innocuous AI-2 analogs pose less evolutionary pressure on bacteria than other current bacteriostatic or bacteriocidal anti-microbials responsible for drug resistant strains.
Detailed Description
Inventors at the University of Maryland, College Park have created unique QS inhibiting AI-2 (Autoinducer-1) based analogs that disrupt biofilm formation and consequently bacterial pathogenicity. Researchers have shown for the first time that phosphorylated branched DPD (dihydroxy-pentane-dione) AI-2 analogs are QS antagonists. They can replace the previously used AHL inhibitors which are species specific. The ubiquitous AI-2 is capable of inhibiting and modulating QS among multiple pathogenic species simultaneously. These quorum quenching analogs could potentially have extensive applications in both medical and non-medical fields.
File Number: LS-2010-005
Web site: http://otc.umd.edu
This innovation currently is not available for online licensing. Please contact the case manager at University of Maryland for more information.
Find more innovations
